Close Menu

siRNA

Thomas Cech, Jeffery Vick

Strands: Feb 26, 2009

Premium

Tekmira Pharmaceuticals, MDRNA

Sylentis will perform the initial clinical trial on its own in Spain for logistical reasons, but expects to later test the topically administered drug in other countries, including the US, according to a company official.

IP Update: Feb 19, 2009

Premium

USPTO Publishes Six RNAi-Related Patent Applications

Strands: Feb 19, 2009

Premium

MDRNA, Roche, Arrowhead Research, Rosetta Genomics, Alnylam Pharmaceuticals, Genesis Research and Development

During a conference call held this week to discuss Arrowhead Research's fiscal first-quarter financial results, President and CEO Christopher Anzalone said that the company was in a position to stay afloat for at least the next nine months.

The researchers evaluated the effects of small molecules in both in vitro enzymatic assays and cell-based assays to develop what they said are the first isoform-selective phospholipase D inhibitors, which are potential antimetastatic agents.

IP Update: Feb 5, 2009

Premium

USPTO Publishes Seven RNAi-Related Patent Applications

Pages

A letter criticizing actions by the US government and research institutions toward Chinese and Chinese-American scientists has garnered more than a hundred signatories.

NPR reports that researchers in New York are investigating whether it is possible to edit the genomes of human sperm.

In an opinion piece at the Nation, Sarah Lawrence College's Laura Hercher argues that everyone should be able to access prenatal genetic testing.

In Nature this week: ancient DNA uncovers presence of Mediterranean migrants at a Himalayan lake, and more.